一个临床算法来识别患有葡萄糖-6-酸盐脱酶p.Val68Met变异的糖尿病治疗不足风险的人
medRxiv : the preprint server for health sciences
|January 27, 2025
概括
一个新的算法识别了因葡萄糖-6-酸脱酶 (G6PD) 缺乏症而低估糖化血红蛋白 (HbA1c) 风险的个体. 该工具有助于针对性的G6PD测试和糖尿病管理.
科学领域:
- 临床化学 临床化学
- 遗传学 是一个遗传学.
- 糖尿病管理 糖尿病管理
背景情况:
- 糖化血红蛋白 (HbA1c) 对于糖尿病监测至关重要.
- 葡萄糖-6-酸盐脱酶 (G6PD) 缺乏可以导致系统地低估HbA1c.
- 识别患有G6PD缺乏症的个体对于准确的糖尿病护理至关重要.
研究的目的:
- 开发一种临床算法,用于识别因G6PD缺乏症而面临HbA1c低估风险的个体.
- 在此风险评估中使用常规的临床实验室测量.
- 为指导有针对性的G6PD基因型定型和糖尿病监测策略.
主要方法:
- 在四个队伍中对122,307名黑人种族参与者的分析.
- 使用的血糖,HbA1c和红细胞分布宽度测量.
- 开发并验证了用于G6PD缺陷风险预测的递归分区算法.
主要成果:
- 该算法在半双的男性和同双的女性中对G6PD缺陷预测的精度和回忆率有所不同.
- 预测可能的G6PD缺乏与糖尿病患者20年糖尿病视网膜病变的发生率高出1.4倍有关.
- 视网膜病变发生率的P值为0.003.
结论:
- 一个简单的临床算法可以识别可能受益于G6PD基因型定型的个体.
- 该算法支持关于基于葡萄糖的糖尿病监测的知情决策.
- 这种方法可以提高风险人群中糖尿病管理的准确性.
更多相关视频
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
12.9K
10:35Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
2.7K
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
500
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
500
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Hypoglycemia and Glucagon
150
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
150
Pathophysiology of Diabetes
854
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
854
Diabetes: Management and Pharmacotherapy
233
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
233
